Your browser doesn't support javascript.
loading
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.
Catucci, Irene; Peterlongo, Paolo; Ciceri, Sara; Colombo, Mara; Pasquini, Graziella; Barile, Monica; Bonanni, Bernardo; Verderio, Paolo; Pizzamiglio, Sara; Foglia, Claudia; Falanga, Anna; Marchetti, Marina; Galastri, Laura; Bianchi, Tiziana; Corna, Chiara; Ravagnani, Fernando; Bernard, Loris; Fortuzzi, Stefano; Sardella, Domenico; Scuvera, Giulietta; Peissel, Bernard; Manoukian, Siranoush; Tondini, Carlo; Radice, Paolo.
Afiliação
  • Catucci I; 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy [2] Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Peterlongo P; 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy [2] Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ciceri S; 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy [2] Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Colombo M; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pasquini G; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Barile M; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Verderio P; Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pizzamiglio S; Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Foglia C; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Falanga A; Department of Immunohematology and Transfusion Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Marchetti M; Department of Immunohematology and Transfusion Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Galastri L; Associazione Italiana Volontari Sangue Comunale Milano, Milan, Italy.
  • Bianchi T; Associazione Italiana Volontari Sangue Comunale Milano, Milan, Italy.
  • Corna C; Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Ravagnani F; Immunohematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bernard L; Department of Experimental Oncology, Istituto Europeo di Oncologia, Cogentech, Milan, Italy.
  • Fortuzzi S; IFOM Cogentech, Consortium for Genomic Technologies, Milan, Italy.
  • Sardella D; IFOM Cogentech, Consortium for Genomic Technologies, Milan, Italy.
  • Scuvera G; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tondini C; Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Genet Med ; 16(9): 688-94, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24556926

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteínas Supressoras de Tumor / População Branca / Mutação País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteínas Supressoras de Tumor / População Branca / Mutação País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália